Education
About Us
Working with TipRanks
Follow Us
Geoffrey M.D. Ling Insider Profile
4 Followers
Geoffrey M.D. Ling, Director at Gyre Therapeutics, holds 111.80K shares in Celularity (Ticker: CELU), holds 31.79K shares in Gyre Therapeutics (Ticker: GYRE).
Geoffrey M.D. Ling has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Geoffrey M.D. Ling holds in companies
Most Profitable Insider Trade
The most profitable trade made by Geoffrey M.D. Ling
Geoffrey M.D. Ling's Trading History
Gyre Therapeutics
Jan 07, 2022
Director
Uninformative Buy
―
$253.68K
Celularity
Nov 21, 2025
Director
Uninformative Buy
―
$221.35K
List of latest transactions for each holding click on a transaction to see Geoffrey M.D. Ling's performance on stock
You May Also Like
Geoffrey M.D. Ling insider profile FAQ
What is the percentage of profitable transactions made by Geoffrey M.D. Ling?
The percentage of profitable transactions made by Geoffrey M.D. Ling is ―.
What is the average return per transaction made by Geoffrey M.D. Ling?
The average return per transaction made by Geoffrey M.D. Ling is ―.
What stocks does Geoffrey M.D. Ling hold?
Geoffrey M.D. Ling holds: GYRE, CELU stocks.
What was Geoffrey M.D. Ling’s latest transaction?
Geoffrey M.D. Ling latest transaction was an Uninformative Buy of ―.
What was Geoffrey M.D. Ling's most profitable transaction?
Geoffrey M.D. Ling’s most profitable transaction was an Informative Buy of GYRE stock on February 27, 2020. The return on the trade was 5.60%.
What is Geoffrey M.D. Ling's role in Gyre Therapeutics?
Geoffrey M.D. Ling's role in Gyre Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.